|
Report No. : |
330052 |
|
Report Date : |
14.07.2015 |
IDENTIFICATION DETAILS
|
Correct Name : |
FARMACEUTICA PARAGUAYA S.A. |
|
|
|
|
Registered Office : |
Avda. Aviadores del Chaco 2462 entre Santa Teresa y San Blas, Asuncion
|
|
|
|
|
Country : |
Paraguay |
|
|
|
|
Year of Establishment : |
1975 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Processing and Marketing of Medical
Specialties for Human Use. |
|
|
|
|
No. of Employees : |
500 Employees |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Paraguay |
B1 |
B1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PARAGUAY - ECONOMIC OVERVIEW
Landlocked Paraguay has a market economy distinguished by a large informal sector, featuring re-export of imported consumer goods to neighboring countries, as well as the activities of thousands of microenterprises and urban street vendors. A large percentage of the population, especially in rural areas, derives its living from agricultural activity, often on a subsistence basis. Because of the importance of the informal sector, accurate economic measures are difficult to obtain. On a per capita basis, real income has stagnated at 1980 levels. The economy grew rapidly between 2003 and 2008 as growing world demand for commodities combined with high prices and favorable weather to support Paraguay's commodity-based export expansion. Paraguay is the sixth largest soy producer in the world. Drought hit in 2008, reducing agricultural exports and slowing the economy even before the onset of the global recession. The economy fell 3.8% in 2009, as lower world demand and commodity prices caused exports to contract. The government reacted by introducing fiscal and monetary stimulus packages. Growth resumed at a 13% level in 2010, the highest in South America, but slowed in 2011-13 as the stimulus subsided and severe drought and outbreaks of foot-and-mouth disease led to a drop in beef and other agricultural exports. The economy took another leap in 2014, largely due to strong export growth. Political uncertainty, corruption, limited progress on structural reform, and deficient infrastructure are the main obstacles to long-term growth.
Source
: CIA
FARMACEUTICA
PARAGUAYA S.A.
*FAPASA*
R.U.C. Nº 80006276-0
BEGINNER OF ACTIVITIES, INCORPORATED IN 1975. NO FINANCIAL DATA PROVIDED ONLY TO BANKS AND TAX COMPTROLLERS. NO NEGATIVE REGISTERED. APT FOR CURRENT CREDITS.
PROCESSING AND
MARKETING OF MEDICAL SPECIALTIES FOR HUMAN USE.
LEGAL FORM:
PUBLIC
LIMITED COMPANY
CREATED: 1975
REGISTERED RPC: 1975
DURATION: UNLIMITED
END OF FISCAL YEAR: 31.12
Accountant:
Liliana Garcete
Legal and administrative address:
Avda. Aviadores del Chaco 2462 entre Santa Teresa y San Blas, Asuncion,
Republic of Paraguay.
Phone: 00595-21 614450/4
E.Mail: liliana.garcete@fapasa.com.py
Web: www.fapasa.com.py
LEGAL
REPRESENTATIVE: OSVALDO FORMENTO
Using signature: It is in charge of before mentioned.
Reference activities
were initiated directly by the company, which is engaged in the development,
production and marketing of medicines for human use.
In 2004, health authorities in Argentina, Uruguay and Paraguay holder awarded
to GMP compliance certification for the marketing of products in MERCOSUR. It
exports to Brazil and has won approval from the health authorities of Pakistan,
Colombia, Mexico, so the recertification cone with scope to Argentina and
Paraguay, for 5 years.
The company has licenses for the following
international laboratories:
CELGENE (EE.UU-SUIZA)
ALPHEX PHARMA (SUIZA)
TOLMAR (USA)
MEIJI SEIKA (JAPON)
DEBIOPHARM (SUIZA)
LABORATORIOS PHOENIX (ARGENTINA)
Attended by the
Accountant Garcete Liliana, who showed that by directives primarily responsible
for the company did not provide reports, let alone of financial character.
A society is given
possession of the property in which it operates its head office and production
plant, which by their characteristics have a significant value of realization.
It also has several vehicles of different models.
Is dedicated to the development of the abovementioned activities.
Imports from Brazil, Argentina, India, Switzerland and exports to Brazil,
Argentina, Colombia, Mexico and Pakistan.
CELGENE (SWITZERLAND)
ALPEX PHARMA (SWITZERLAND)
DEBIOPHARM (SWITZERLAND)
* 500 EMPLOYEES
Plant of production:
Waldino Ramon Lovera y del Carmen, Fernando de la Mora, Republic of Paraguay.
Branchs:
Gral. Eugenio Garay nº 112 esq. Juan A. Roa, Cnel. Oviedo, Paraguay.
- Calle UV Monday, Ciudad del Este, Paraguay.
- Gral. Cabañas 235, Encarnacion, Paraguay.
BANCO ATLAS
BANCO CONTINENTAL
BANCO REGIONAL
Centralhouse
INSURANCE:
----------
MAPFRE S.A.
It is commercially
related to companies of this one and other places, good part of which offer its
credit support without making until the moment objections on the modes of
payment that it sustains.
* FULFILLMENT: NOT OBJECTED.
The lack of
negative antecedents makes viable the credit relation with the company, by
current credits and additional guarantees.
* APT FOR CURRENT CREDITS.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.47 |
|
UK Pound |
1 |
Rs.98.47 |
|
Euro |
1 |
Rs.70.69 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIT |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.